Solli E, Bevilacqua A, Wenes M, Migliorini D, van der Veen L, Skånland SS, Di Conza G, Taskén K(2026) The PI3Kδ inhibitor roginolisib (IOA-244) preserves T-cell function and activity Mol Oncol(in press) DOI 10.1002/1878-0261.70203, PubMed 41568714
Hermansen JU, Athanasiadis P, Yin Y, Rise AF, Arribas AJ, Cascione L, Russnes HG, Helland Å, Mato AR, Bertoni F, Tjønnfjord GE, Aittokallio T, Skånland SS(2025) Proteasome inhibition overcomes resistance to targeted therapies in B-cell malignancy models and in an index patient Cell Death Dis, 16(1), 555 DOI 10.1038/s41419-025-07884-7, PubMed 40701968
Våtsveen TK, Giliberto M, Bjornsdottir V, Centonze F, Besse A, Frey Y, Skånland SS, Tveita A, Alirezaylavasani A, Imbery JF, Misund K, Reiterer V, Zahoor M, Driessen C, Besse L, Tasken K, Schjesvold FH, Farhan H, Munthe LA(2025) Targeting proteostasis in multiple myeloma through inhibition of LTK Leukemia, 39(9), 2237-2245 DOI 10.1038/s41375-025-02682-8, PubMed 40634511
